Ensuring Africa has the capacity to manufacture vaccines
To promote the establishment of sustainable human vaccine manufacturing capacity in Africa.
The African Vaccine Manufacturing Initiative (AVMI) is a non-profit, advocacy group that promotes the establishment of sustainable human vaccine manufacturing capacity in Africa. Established in 2012, AVMI currently represents several vaccine manufacturers across the continent.
AVMI was instrumental in the establishment of the Partnership for African Vaccine Manufacturing (PAVM) by the Africa Centres for Disease Control and Prevention (Africa CDC). AVMI continues to support Africa CDC through the PAVM’s new iteration as the Platform for Harmonised African Health Manufacturing (PHAHM) to achieve the African Union’s ambitious goal of supplying at least 60% of Africa’s vaccine needs by 2040, up from the current 1%.